Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKRP) Research & Development (2016 - 2025)

Bruker's Research & Development history spans 16 years, with the latest figure at $99.6 million for Q4 2025.

  • For Q4 2025, Research & Development fell 4.6% year-over-year to $99.6 million; the TTM value through Dec 2025 reached $395.2 million, up 4.97%, while the annual FY2025 figure was $395.2 million, 4.97% up from the prior year.
  • Research & Development reached $99.6 million in Q4 2025 per BRKRP's latest filing, up from $98.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $104.4 million in Q4 2024 to a low of $52.1 million in Q3 2021.
  • Average Research & Development over 5 years is $76.2 million, with a median of $71.1 million recorded in 2023.
  • Peak YoY movement for Research & Development: skyrocketed 37.59% in 2024, then dropped 4.6% in 2025.
  • A 5-year view of Research & Development shows it stood at $58.1 million in 2021, then increased by 9.29% to $63.5 million in 2022, then skyrocketed by 31.5% to $83.5 million in 2023, then increased by 25.03% to $104.4 million in 2024, then decreased by 4.6% to $99.6 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Research & Development are $99.6 million (Q4 2025), $98.3 million (Q3 2025), and $100.2 million (Q2 2025).